Get Email Updates
Analysts' EPS Estimates
Analysts' Price Targets
Analysts' New Coverage
Free Email Newsletter
Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:
Neos Therapeutics’ (NEOS) “Buy” Rating Reiterated at BMO Capital Markets
Pacira Pharmaceuticals Inc. (PCRX) Stock Rating Reaffirmed by BMO Capital Markets
Mallinckrodt PLC (MNK) Rating Reiterated by BMO Capital Markets
RANDSTAD HLDGS NV UNSP ADR EACH REPR 0.5 (RANJY) Rating Lowered to Strong Sell at Zacks Investment Research
Flexion Therapeutics’ (FLXN) Buy Rating Reaffirmed at BMO Capital Markets
Quotient Technology Inc. (QUOT) Downgraded to Hold at Zacks Investment Research
Regeneron Pharmaceuticals Inc. (REGN) Receives “Buy” Rating from Leerink Swann
Zacks Investment Research Downgrades QTS Realty Trust Inc. (QTS) to Sell
© Copyright American Banking and Market News 2006-2016. All rights reserved.
Content on this website is not meant to be a recommendation or an offer to buy or sell any security.
to read our full disclaimer.